Skip to main content

Respect for Human Subjects: Ethics in Research Design

  • Chapter
  • First Online:
Dermatoethics

Abstract

Respect for human subjects serves as a foundation for the development and assessment of ethics in clinical research. In the past, however, significant violations of this principle have taken place. Responding to these atrocities, numerous guiding documents, including the Declaration of Helsinki and the Belmont Report, were created to establish a framework for the regulation of modern research design. These documents establish specific interpretations of respect for human subjects in clinical research and highlight the crucial role of voluntary participation and informed consent in this context. However, modern research design must still be subject to scrutiny and reevaluation. In this chapter, modern clinical research scenarios that exist in a sort of “ethical gray area” are explored in a case-based format. These include the role of placebo-controlled trials for diseases with well-accepted treatments, off-label clinical use of accepted treatments, and front-door consents. Because clinical research maintains a delicate balance between benefit for an individual and benefit for a population, the potential for harm to, or loss of respect for, research participants must be constantly considered.

Clinical research seeks to address clinical knowledge gaps, create new knowledge about disease etiology and treatment, and, improve patient care. Human research participants are key players in research development and conduct. Protection of human subjects, by balancing benefits of research against potential harms, is essential. Research ethics are chiefly governed by the principle of respect for human subjects in a way that allows them to participate in research voluntarily, free from coercion, and with minimal harm.

Historically, principles and regulations that serve to protect human subjects in clinical research were developed as a response to violations of basic human dignity in the context of research. For example, Nazi researchers exploited human subjects through horrific experiments including poisoning, bacterial inoculation, and simulating potentially fatal conditions like high altitude and freezing temperatures. These experiments were conducted in the name of advancing science and medicine despite the torture and even death of many people. The US Public Health Service Syphilis Study at Tuskegee (commonly referred to as “the Tuskegee Syphilis Experiment”) is another example of research conducted without respect for human subjects. In 1932, 399 men with syphilis in Macon County, Alabama were followed longitudinally to document the effects of untreated syphilis. The study continued with the support of numerous physicians and medical societies, denying subjects treatment even as penicillin became the first-line treatment for syphilis. It was not until a 1972 Associated Press article about the study incited a large public response to the study that it was officially ended. Disrespect for human subjects in these and numerous other cases over the years underscores the need for strong ethical standards in human subject research.

This chapter will review some of the landmark documents that influence ethical research standards and present example cases of ethical dilemmas that continue to arise in clinical research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Twenty years after: the legacy of the Tuskegee syphilis study. Hastings Cent Rep. 1992;22(6):29–40.

    Google Scholar 

  2. The Nuremberg Code. The BMJ, British Medical Journal Publishing Group. 1947.

    Google Scholar 

  3. World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Org. 2001;79(4):373.

    Google Scholar 

  4. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont report: ethical principles and guidelines for the protection of human subjects of research. Bethesda: The Commission; 1978.

    Google Scholar 

  5. Council for International Organizations of Medical Sciences (CIOMS). International ethical guidelines for health-related research involving humans. 4th ed. Geneva: CIOMS; 2016.

    Google Scholar 

  6. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. [Accessed on 2019 May 15]. Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf.

  7. Office for Human Research Protections. Revised Common Rule Regulatory Text. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/revised-common-rule-regulatory-text/index.html.

  8. Emanuel EJ, Miller FG. The ethics of placebo-controlled trials—a middle ground. NEJM. 2001;345(12):915–9.

    Article  CAS  Google Scholar 

  9. Kavanaugh A. Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis. Ann Rheum Dis. 2005;64:46–8.

    Google Scholar 

  10. Jemec G, Gottlieb A, Forman S, Giamarellos-Bourboulis E, et al. Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa: results from PIONEER II, a phase 3, randomized, placebo-controlled trial. J Am Acad Dermatol. 2015;72(5):AB45.

    Google Scholar 

  11. US Food and Drug Administration. “Off-label” and investigational use of marketed drugs, biologics, and medical devices: guidance for institutional review boards and clinical investigators. [Access 2019 May 28]. Available https://www.fda.gov/regulatory-information/search-fda-guidance-documents/label-and-investigational-use-marketed-drugs-biologics-and-medical-devices.

  12. Piasecki J, Dranseika V. Research versus practice: the dilemmas of research ethics in the era of learning health-care systems. Bioethics. 2019;00:1–8.

    Google Scholar 

  13. Emory Institutional Review Board: Frequently Asked Questions [Internet]. [cited 2019 May 23]. Available from: http://www.irb.emory.edu/forms/faqs.html.

  14. Ost JA, Newton PW, Neilson DR, Cioffi JA, Wackym PA, Perkins RS. Progressive consent and specimen accrual models to address sustainability: a decade’s experience at an Oregon biorepository. Biopreserv Biobank. 2017;15(1):3–8.

    Article  Google Scholar 

  15. Strech D, Bein S, Brumhard M, Eisenmenger W, Glinicke C, Herbst T, et al. A template for broad consent in biobank research. Results and explanation of an evidence and consensus-based development process. Eur J Med Genet. 2016;59(6–7):295–309.

    Article  CAS  Google Scholar 

  16. Richter G, Krawczak M, Lieb W, Wolff L, Schreiber S, Buyx A. Broad consent for health care-embedded biobanking: understanding and reasons to donate in a large patient sample. Genet Med. 2018;20(1):76–82.

    Article  Google Scholar 

  17. De Vries RG, Tomlinson T, Kim HM, Krenz C, Haggerty D, Ryan KA, et al. Understanding the public’s reservations about broad consent and study-by-study consent for donations to a biobank: results of a national survey. PLoS One. 2016;11(7):e0159113.

    Article  Google Scholar 

  18. Cocanour CS. Informed consent-It’s more than a signature on a piece of paper. Am J Surg. 2017;214(6):993–7.

    Article  Google Scholar 

  19. Wan MT, Torigian DA, Alavi A, Alvarez J, Chiesa Fuxench ZC, Noe MH, et al. Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials. J Am Acad Dermatol. 2019;80(6):1630–9.

    Article  Google Scholar 

  20. Ells C, Thombs BD. The ethics of how to manage incidental findings. CMAJ. 2014;186(9):655–6.

    Article  Google Scholar 

  21. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36(2):219–48, 211

    Article  Google Scholar 

  22. Weiner C. Anticipate and communicate: ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues). Am J Epidemiol. 2014;180(6):562–4.

    Article  Google Scholar 

  23. National Heart, Lung, and Blood Institute working group, Fabsitz RR, McGuire A, Sharp RR, Puggal M, Beskow LM, et al. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet. 2010;3(6):574–80.

    Article  Google Scholar 

  24. Appelbaum PS, Parens E, Waldman CR, Klitzman R, Fyer A, Martinez J, et al. Models of consent to return of incidental findings in genomic research. Hast Cent Rep. 2014;44(4):22–32.

    Article  Google Scholar 

  25. Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249–55.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Howa Yeung .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kosche, C., Rolader, R., Yeung, H. (2021). Respect for Human Subjects: Ethics in Research Design. In: Bercovitch, L., Perlis, C.S., Stoff, B.K., Grant-Kels, J.M. (eds) Dermatoethics. Springer, Cham. https://doi.org/10.1007/978-3-030-56861-0_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56861-0_41

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56860-3

  • Online ISBN: 978-3-030-56861-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics